Revenue for Biogen (BIIB)
According to Biogen's latest reported financial statements, the company's current revenue (TTM) is $9.81B USD. Revenue is the total income from selling goods or services before any expenses. Unlike net income (earnings), revenue does not subtract operating costs, taxes, or other charges. Figures are in USD; chart and tables below use historical filings (not a live revenue-per-second estimate).
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
BIIB
Currently viewingRevenueSwitch metric
TTM (last 4 quarters)
$9.81B
YoY change
+1.4%
5Y CAGR
-6.1%
Peak year (2019)
$14.38B
Cumulative revenue
$181.17B
Revenue history chart for Biogen (BIIB) from 1985 to 2025
Revenue history table for Biogen (BIIB) from 1985 to 2025
| Fiscal year | Period ended | Reported | Revenue | YoY |
|---|---|---|---|---|
| 2025 | $9.81B | +1.4% | ||
| 2024 | $9.68B | -1.6% | ||
| 2023 | $9.84B | -3.3% | ||
| 2022 | $10.17B | -7.4% | ||
| 2021 | $10.98B | -18.3% | ||
| 2020 | $13.44B | -6.5% | ||
| 2019 | $14.38B | +6.9% | ||
| 2018 | $13.45B | +9.6% | ||
| 2017 | $12.27B | +7.2% | ||
| 2016 | $11.45B | +6.4% | ||
| 2015 | $10.76B | +10.9% | ||
| 2014 | $9.70B | +40.0% | ||
| 2013 | $6.93B | +25.7% | ||
| 2012 | $5.51B | +9.2% | ||
| 2011 | $5.05B | +7.0% | ||
| 2010 | $4.72B | +7.7% | ||
| 2009 | $4.38B | +6.8% | ||
| 2008 | $4.10B | +29.2% | ||
| 2007 | $3.17B | +18.2% | ||
| 2006 | $2.68B | +56.6% | ||
| 2005 | $1.71B | +7.4% | ||
| 2004 | $1.60B | +757.3% | ||
| 2003 | $186.13M | -54.0% | ||
| 2002 | $404.22M | -61.2% | ||
| 2001 | $1.04B | +12.6% | ||
| 2000 | $925.66M | +16.5% | ||
| 1999 | $794.43M | +42.5% | ||
| 1998 | $557.59M | +28.5% | ||
| 1997 | $434.04M | +56.6% | ||
| 1996 | $277.09M | +82.7% | ||
| 1995 | $151.69M | -3.0% | ||
| 1994 | $156.34M | +14.6% | ||
| 1993 | $136.40M | +10.3% | ||
| 1992 | $123.70M | +101.5% | ||
| 1991 | $61.40M | +22.6% | ||
| 1990 | $50.10M | +75.8% | ||
| 1989 | $28.50M | +38.3% | ||
| 1988 | $20.60M | +139.5% | ||
| 1987 | $8.60M | +34.4% | ||
| 1986 | $6.40M | -57.6% | ||
| 1985 | $15.10M | — |
Revenue values are taken from Biogen's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
In 2025, Biogen (BIIB) revenue totalled $9.81B – edged up 1.4% year-over-year.
Through 2020–2025 (5 years), Biogen revenue delivered a -6.1% annualised rate; with a net decline across the window.
Between 2019 and 2025, Biogen revenue plunged 31.8%, falling from $14.38B to $9.81B.
The dataset's maximum revenue sits at $14.38B (2019); the minimum reading of $6.40M dates to 1986.
Biogen (BIIB) sits 9th of 8 Healthcare peers we track on this metric, against a peer median of $65.09B.
Biogen Revenue by Year
Biogen Revenue 2025: $9.81B
Biogen revenue in 2025 was $9.81B, edged up 1.4% from 2024.
Biogen Revenue 2024: $9.68B
Biogen revenue in 2024 was $9.68B, edged down 1.6% below 2023.
Biogen Revenue 2023: $9.84B
Biogen revenue in 2023 was $9.84B, edged down 3.3% below 2022.
Biogen Revenue 2022: $10.17B
Biogen revenue in 2022 was $10.17B, declined 7.4% below 2021.
Biogen Revenue 2021: $10.98B
Biogen revenue in 2021 was $10.98B.
See more financial history for Biogen (BIIB).
Sector peers — Revenue
Companies in the same sector as Biogen, ranked by their latest revenue.
| Company | Revenue | Sector |
|---|---|---|
| UnitedHealth Group Incorporated (UNH) | $447.57B | Healthcare |
| Novo Nordisk A/S (NVO) | $309.06B | Healthcare |
| Johnson & Johnson (JNJ) | $94.19B | Healthcare |
| Eli Lilly and Company (LLY) | $65.18B | Healthcare |
| Merck & Co., Inc. (MRK) | $65.01B | Healthcare |
| AbbVie Inc. (ABBV) | $61.16B | Healthcare |
| AstraZeneca PLC (AZN) | $58.74B | Healthcare |
| Amgen Inc. (AMGN) | $36.74B | Healthcare |
Frequently asked questions
What is Biogen's revenue?
- Latest reported revenue for Biogen (BIIB) is $9.81B (period ending December 31, 2025).
How has Biogen revenue changed year-over-year?
- Biogen (BIIB) revenue changed +1.4% year-over-year on the latest annual filing.
What is the long-term growth rate of Biogen revenue?
- Biogen (BIIB) revenue compound annual growth rate is -6.1% over the most recent 5 years available.
When did Biogen revenue hit its highest annual value?
- Biogen revenue reached its highest annual value of $14.38B in 2019.
What was Biogen revenue in 2024?
- Biogen (BIIB) revenue in 2024 was $9.68B.
What was Biogen revenue in 2025?
- Biogen (BIIB) revenue in 2025 was $9.81B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
BIIB Overview
Company profile, financial tools, and key metrics
BIIB Revenue Counter
Earns $311.09 every second. See per minute, hour, and day.
BIIB Earnings Counter
Earns $41.01 per second net profit. See per minute, hour, and day.
BIIB Economic Scale
Exceeds Bermuda's GDP. Compare with world economies.
BIIB What If Invested
What if you had invested $1,000? See historical returns from any date.
BIIB How It Makes Money
Discover visual breakdown of $9.81B in revenue — where it comes from and where it goes.
BIIB Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
BIIB Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
BIIB Daily Price Character
Explosive · 48.1% historical win rate (green days). Streaks & record days.
BIIB Buybacks
Recent repurchase activity. Shareholder yield & SBC comparison.
BIIB Stock Split History
2 splits on record. Dates, ratios, and cumulative multiple.